Navigation Links
Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates

'Superbug' Prevalence Data from 1,237 Facilities Demonstrates Public Health Threat; Colonization and Infections Span All States, Across Healthcare Facility Units

SAN JOSE, Calif., June 25, 2007 /PRNewswire-USNewswire/ -- The Association for Professionals in Infection Control and Epidemiology (APIC) today released initial results from a nationwide study of 1,237 U.S. healthcare facilities, examining the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA), a virulent multi-drug resistant organism. Findings demonstrate MRSA prevalence rates to be at least 46 cases per 1,000 patients -- significantly more widespread and established than previous estimated rates.

In the most comprehensive MRSA survey of its kind, infection control personnel from approximately 21 percent of U.S. healthcare facilities in all 50 states participated in the study. The survey took a one-day "snapshot" of MRSA prevalence at these facilities between October and November 2006. The detailed survey looked at facilities caring for virtually every type of patient: acute care, cancer, cardiac, pediatric, rehabilitation and long-term care, and included county, public and private facilities. The survey also represents a cross-section of all sizes of facilities, from less than 100 to more than 300 bed facilities.

This is the first study to measure rates of both MRSA infection and colonization (patients carrying and able to transmit MRSA), to more accurately determine MRSA prevalence. Of the 46 in 1,000 MRSA patients, approximately 34/1,000 were infected while 12/1,000 patients were colonized.

Additionally, the survey determined that 77 percent of MRSA patients were identified within 48 hours of admission. This finding suggests that 35 out of 46 patients walk into healthcare facilities with MRSA, having acquired it either in a previous stay in a healthcare facility or in the community.

"APIC's MRSA survey pres ents a grim picture," said William Jarvis, MD, principal investigator of the study and president and co-founder of Jason and Jarvis Associates, a private consulting firm in healthcare epidemiology. "The findings argue for immediate, aggressive efforts to detect and prevent transmission of MRSA. Because the true magnitude of the total MRSA burden in the U.S. healthcare population is unknown, our objective was to provide the first national estimate of MRSA in U.S. healthcare facilities."

The research indicated that once MRSA cases are identified, healthcare facilities employ recommended practices to prevent transmission of the organism, such as practicing barrier precautions (use of gloves and gowns), hand hygiene and isolating MRSA patients. 81 percent of patients in the study were not identified until they presented signs or symptoms of an active infection prompting doctors to order lab tests. This finding implies that a significant number of patients are potentially transmitting MRSA to healthcare workers and other patients before the bacteria are identified.

"Quite simply this survey is a wake up call for healthcare facilities to save lives by dedicating more resources to infection prevention and control because the transmission of MRSA is preventable," said Denise Murphy, president of APIC and Vice President of Safety and Quality, and Chief Patient Safety and Quality Officer at Barnes-Jewish Hospital at Washington University Medical Center in St. Louis. "Some healthcare facilities are aggressively addressing MRSA, but the scope of this public health threat demands commitment and participation from every hospital, at all levels of the facility. Hospitals should commit the resources to conduct a thorough risk assessment of patient populations and implement viable strategies to prevent MRSA and other antimicrobial-resistant infections. These measures could help prevent this epidemic from continuing to spiral upward and out of control."

APIC guid elines for the elimination of MRSA transmission include a risk assessment to identify high-risk areas for MRSA within the hospital; surveillance program to outline activities and procedures to identify MRSA cases; adherence to CDC hand hygiene guidelines; use of contact precautions (e.g., gloves, gowns and separating MRSA patients from other patients); environmental and equipment cleaning and decontamination, especially items that are close to patients such as bedrails and bedside equipment, and targeted active surveillance cultures (testing of high-risk groups).

APIC's mission is to improve health and patient safety by reducing risks of infection and other adverse outcomes. The Association's more than 11,000 members have primary responsibility for infection prevention, control and hospital epidemiology in health care settings around the globe. APIC advances its mission through education, research, collaboration, practice guidance, public policy, and credentialing. Visit APIC online at http://www.apic.org

CONTACT: Jonathan Osmundsen, +1-202-261-2869, Cell: +1-512-751-5309,, for APIC jonathan.osmundsen@mslpr.com

Web site: http://www.apic.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
2. Actilyse (alteplase) Recommended by National Institute for Health and Clinical Excellence for Treatment of Acute Ischaemic Stroke
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. First-of-its-Kind National Report Reveals Estimated High Prevalence and Heavy Cost of Type 2 Diabetes Complications in America
6. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
7. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
8. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
9. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
10. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
11. Nationwide MRSA Prevalence Study to Demonstrate Full Scope of Superbug Threat Facing U.S. Healthcare Facilities and Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):